Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Saladax signs supply agreement with Karolinska University Hospital
The test provides oncologists with a new tool for monitoring blood level of 5-FU in cancer patients undergoing chemotherapy. This rapid test is said to be faster than
The test provides oncologists with a new tool for monitoring blood level of 5-FU in cancer patients undergoing chemotherapy. This rapid test is said to be faster than
In order to preserve the company’s remaining cash resources, the company’s employees were released from employment, except for Shawn Cain, the company’s president and CEO, and Scott Hayashi,
The endpoint of the study is to determine if glucose levels will drop when subjects use Generex Oral-lyn, the company’s proprietary oral insulin spray product, with the company’s
This milestone signals the initiation by Merck of a Phase I clinical study of an investigational compound using the MicroDose dry powder inhaler (DPI) technology. As previously announced,
In each of the two placebo-controlled efficacy and safety trials, patients treated with tranexamic acid MR experienced a significant reduction in mean monthly menstrual blood loss compared with
According to Capricorn, korkoat beads accommodate high drug loads; modified drug release can be achieved by incorporating release-modifying agents inside the bead, in the coating, or in both.
This multi-site trial enrolled patients with cystoid macular edema associated with retinal vein occlusion and post operative cataract surgery. IBI-20089 is a drug product based on Icon Bioscience’s
The PhotoMedex (PHMD) division provides mobile laser services in 11 Northeast, Mid-Atlantic and Southeast states, serving 18 individual local markets expanding PRI’s geographic coverage to a total of
Dr Gussak joins NewCardio from Boehringer Ingelheim Pharmaceuticals, where he held a senior executive role for the past year. Dr Gussak received his MD from Tartu University School
As part of the three-year agreement, the companies will employ the same underlying technology used in their previously announced joint project, a diagnostic for the differential diagnosis of